1254098-87-7

Basic information

• Product Name: 4-[({5-[2-({[4-({[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}methyl)phenyl]methyl}carbamoyl)ethyl]-2-phenylphenyl}carbamoyl)oxy]-1,1-dimethylpiperidin-1-ium trifluoroacetate
• CAS NO: 1254098-87-7
• Molecular Weight: 831.889
• Mol File: 1254098-87-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-[({5-[2-({[4-({[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}methyl)phenyl]methyl}carbamoyl)ethyl]-2-phenylphenyl}carbamoyl)oxy]-1,1-dimethylpiperidin-1-ium trifluoroacetate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[({5-[2-({[4-({[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}methyl)phenyl]methyl}carbamoyl)ethyl]-2-phenylphenyl}carbamoyl)oxy]-1,1-dimethylpiperidin-1-ium trifluoroacetate(1254098-87-7)
• EPA Substance Registry System: 4-[({5-[2-({[4-({[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}methyl)phenyl]methyl}carbamoyl)ethyl]-2-phenylphenyl}carbamoyl)oxy]-1,1-dimethylpiperidin-1-ium trifluoroacetate(1254098-87-7)

Safety Data

• Hazardous Substances Data: 1254098-87-7(Hazardous Substances Data)

Upstream product

• 1254102-84-5 5-[(1R)-2-bromo-1-hydroxyethyl]-8-[(4-methoxyphenyl)methoxy]-1,2-dihydroquinolin-2-one 
• 1254102-82-3 1-methylpiperidin-4-yl N-(5-{2-[({4-[(tert-butoxycarbonyl)amino]phenyl}methyl)carbamoyl]ethyl}-2-phenylphenyl)carbamate 
• 76-05-1 trifluoroacetic acid 
• 62978-73-8 5-acetyl-8-hydroxy-2(1H)-quinolinone 
• 1254102-83-4 5-(2-bromoacetyl)-8-[(4-methoxyphenyl)methoxy]-1,2-dihydroquinolin-2-one 
• 956235-09-9 5-acetyl-8-[(4-methoxyphenyl)methoxy]-1,2-dihydroquinolin-2-one 
• 15450-72-3 2-oxo-1,2-dihydroquinolin-8-yl acetate 
• 148-24-3 8-quinolinol 
• 1127-45-3 8-Hydroxyquinoline-N-oxide 

Relevant articles and documents

QUATERNARY AMMONIUM SALT COMPOUNDS

[Problem] The object of the present invention is to provide a novel compound having 132 adrenergic receptor agonist activity and muscarinic receptor antagonist activity. [Means for Solving the Problem] The present invention is a quaternary ammonium salt compounds represented by formula (I), or a pharmaceutically acceptable salt thereof, with superior β32 adrenergic receptor agonist activity and muscarinic receptor antagonist activity.